# DOSE-L1000-Viz: an interactive Shiny application for dose–response transcriptomic analysis, target-centric exploration, and signature search

**Authors:** Junmin Wang

PMC · DOI: 10.1093/bioinformatics/btaf353 · Bioinformatics · 2025-07-03

## TL;DR

DOSE-L1000-Viz is a web tool that helps researchers explore how drugs affect gene expression across different doses and conditions.

## Contribution

It introduces an interactive platform with target-centric compound ranking and signature search using advanced modeling techniques.

## Key findings

- DOSE-L1000-Viz enables dose–response transcriptomic analysis with interactive visualization.
- Generalized additive model-derived signatures outperform traditional methods in benchmarking.
- The tool supports drug repurposing and transcription factor modulation through practical use cases.

## Abstract

Understanding how small molecules perturb gene expression is critical for guiding drug discovery. We present DOSE-L1000-Viz, a Shiny application that facilitates comprehensive exploration of compound-induced transcriptomic responses across doses, time points, and cell types. Powered by a dose–response database, DOSE-L1000-Viz features interactive visualization, target-centric compound ranking based on efficacy and potency, and a signature search module using reference gene sets derived from generalized additive models. We benchmarked signatures derived from generalized additive models against traditional methods and demonstrated the utility of DOSE-L1000-Viz through use cases in transcription factor modulation and drug repurposing.

DOSE-L1000-Viz and the backend data are publicly accessible at: https://dosel1000.com. All code is publicly hosted on GitHub (https://github.com/JmWangBio/DOSEL1000Viz) and archived via Zenodo (https://doi.org/10.5281/zenodo.15532392).

## Full-text entities

- **Genes:** MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609] {aka MRTL, MYCC, bHLHe39, c-Myc}, PAX8 (paired box 8) [NCBI Gene 7849] {aka PAX-8}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, HDAC9 (histone deacetylase 9) [NCBI Gene 9734] {aka HD7, HD7b, HD9, HDAC, HDAC7B, HDAC9B}, NRIP1 (nuclear receptor interacting protein 1) [NCBI Gene 8204] {aka CAKUT3, RIP140}, DNER (delta/notch like EGF repeat containing) [NCBI Gene 92737] {aka UNQ26, bet}, HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase) [NCBI Gene 3156] {aka LDLCQ3, LGMDR28, MYPLG}
- **Diseases:** kidney cancer (MESH:D007680), CD (MESH:D051556), breast cancer (MESH:D001943)
- **Chemicals:** apicidin (MESH:C102351), vorinostat (MESH:D000077337), triterpenoid (MESH:D014315), trichostatin A (MESH:C012589), avicin G (MESH:C478446), pravastatin (MESH:D017035), panobinostat (MESH:D000077767)
- **Cell lines:** MCF7 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0031), HA1E — Homo sapiens (Human), Transformed cell line (CVCL_VU89)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12237504/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12237504/full.md

## References

22 references — full list in the complete paper: https://tomesphere.com/paper/PMC12237504/full.md

---
Source: https://tomesphere.com/paper/PMC12237504